Need for a guideline on the clinical development of thrombopoetin receptor agonists for the treatment of chronic immune (idiopathic) thrombocytopenic purpura - Scientific guideline

This document reflects the need for a guideline on the evaluation of the safety and efficacy of thrombopoetin receptor agonists fin the treatment of chronic immune (idiopathic) thrombocytopenic purpura.

Keywords: Chronic immune idiopathic thrombocytopenic purpura, ITP, thrombopoeting agonists

Current effective version

Concept paper on the need for a guideline on the clinical development of thrombopoetin receptor agonists for the treatment of chronic immune (idiopathic) thrombocytopenic purpura

Draft: consultation closedConsultation dates: 20/05/2010 to 31/08/2010Reference Number: EMA/CHMP/EWP/203111/2010